45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,941
Insurances with rates
10
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 4581256_1 | INJECTION, FERRIC CARBOXYMALTOSE, 1 MG | $29,714 | $29,714 | — | — | 9 |
| 4440253_1 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $20,973 | $20,973 | — | — | 9 |
| 4440266_1 | NON-COVERED ITEM OR SERVICE | $19,775 | $19,775 | — | — | 9 |
| 6375068_1 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $15,049 | $15,049 | — | — | 9 |
| 5504448_1 | INJECTION, BENRALIZUMAB, 1 MG | $10,525 | $10,525 | — | — | 9 |
| 6232151_1 | NON-COVERED ITEM OR SERVICE | $10,098 | $10,098 | — | — | 9 |
| 6555323_1 | INJECTION, IMMUNE GLOBULIN, (GAMUNEX-C/GAMMAKED), NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $8,474 | $8,474 | — | — | 9 |
| 5401968_1 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $7,432 | $7,432 | — | — | 9 |
| 4440301_1 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $7,353 | $7,353 | — | — | 9 |
| 6119607_1 | PURAPLY AM, PER SQUARE CENTIMETER | $6,925 | $6,925 | — | — | 9 |
| 6174956_1 | INJECTION, MEPOLIZUMAB, 1 MG | $6,839 | $6,839 | — | — | 9 |
| 6118536_1 | INJECTION, TEZEPELUMAB-EKKO, 1 MG | $6,539 | $6,539 | — | — | 9 |
| 5549649_1 | Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eye | $6,000 | $6,000 | — | — | 10 |
| 5936072_1 | Injection of anesthetic agent and/or steroid into external genitals and anus nerve | $5,490 | $5,490 | — | — | 10 |
| 5689742_1 | Complex drainage of wound infection after surgery | $5,000 | $5,000 | — | — | 9 |
| 5936794_1 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | $4,455 | $4,455 | — | — | 10 |
| 5936834_1 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | $4,050 | $4,050 | — | — | 10 |
| 4916618_1 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 1 | $4,030 | $4,030 | — | — | 10 |
| 5936736_1 | Injection of lower or sacral spine facet joint using imaging guidance, third and any additional leve | $3,950 | $3,950 | — | — | 9 |
| 6119606_1 | AFFINITY, PER SQUARE CENTIMETER | $3,650 | $3,650 | — | — | 9 |
| 6437695_1 | USTEKINUMAB, FOR INTRAVENOUS INJECTION, 1 MG | $3,644 | $3,644 | — | — | 9 |
| 5666578_1 | Skin substitute graft to wound 100.0 sq cm or more of trunk, arms, or legs, 100.0 sq cm or 1% body a | $3,305 | $3,305 | — | — | 10 |
| 5936755_1 | Injection of anesthetic agent, trigeminal nerve bundle | $3,288 | $3,288 | — | — | 10 |
| 5936675_1 | Injection of upper or middle spine facet joint using imaging guidance, third and any additional leve | $3,060 | $3,060 | — | — | 9 |
| 5936784_1 | Destruction of nerve branches of knee using imaging guidance | $3,038 | $3,038 | — | — | 10 |
| 6000260_1 | AVANOS RFK-2-17-75-2 | $3,000 | $3,000 | — | — | 9 |
| 6344937_1 | INJECTION, PEGFILGRASTIM-JMDB (FULPHILA), BIOSIMILAR, 0.5 MG | $2,896 | $2,896 | — | — | 9 |
| 5936715_1 | Injection of lower or sacral spine facet joint using imaging guidance, second level | $2,770 | $2,770 | — | — | 9 |
| 5936071_1 | Injection of anesthetic agent and/or steroid into external genitals and anus nerve | $2,745 | $2,745 | — | — | 10 |
| 2384299_1 | CT scan of blood vessels of abdomen and pelvis with contrast | $2,672 | $2,672 | — | — | 9 |
| 6412365_1 | INJECTION, MEPOLIZUMAB, 1 MG | $2,656 | $2,656 | — | — | 9 |
| 4337845_1 | Closed treatment of 3 broken lower leg bones at ankle with manipulation | $2,615 | $2,615 | — | — | 9 |
| 5936654_1 | Injection of upper or middle spine facet joint using imaging guidance, second level | $2,558 | $2,558 | — | — | 9 |
| 4337731_1 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 20.1-30.0 cm | $2,547 | $2,547 | — | — | 9 |
| 4352983_1 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 3.1-4.0 cm | $2,500 | $2,500 | — | — | 10 |
| 6229069_1 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 3.1-4.0 cm | $2,500 | $2,500 | — | — | 9 |
| 629762_1 | CT scan of blood vessels of head with contrast | $2,479 | $2,479 | — | — | 9 |
| 629770_1 | CT scan of blood vessels of neck with contrast | $2,479 | $2,479 | — | — | 9 |
| 5935831_1 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidanc | $2,258 | $2,258 | — | — | 9 |
| 4350900_1 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | $2,248 | $2,248 | — | — | 9 |
| 4353328_1 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | $2,248 | $2,248 | — | — | 9 |
| 4353364_1 | TRANSTHORACIC ECHOCARDIOGRAPHY WITH CONTRAST, OR WITHOUT CONTRAST FOLLOWED BY WITH CONTRAST, REAL-TI | $2,248 | $2,248 | — | — | 9 |
| 4617107_1 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | $2,248 | $2,248 | — | — | 9 |
| 5865780_1 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | $2,228 | $2,228 | — | — | 10 |
| 5384502_1 | CT scan of leg before and after contrast | $2,200 | $2,200 | — | — | 9 |
| 630060_1 | CT scan of leg before and after contrast | $2,200 | $2,200 | — | — | 9 |
| 4337733_1 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | $2,176 | $2,176 | — | — | 9 |
| 5996141_1 | AVANOS RFK-2 100X4mm | $2,100 | $2,100 | — | — | 9 |
| 5546917_1 | Ultrasound of heart for congenital defect | $2,100 | $2,100 | — | — | 9 |
| 6033027_1 | AVANOS RFK-2 50X2MM | $2,100 | $2,100 | — | — | 9 |
Showing top 50 of 2,941 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.